EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,430,000 | +35.7% | 43,233 | +19.7% | 0.00% | +33.3% |
| Q3 2016 | $2,528,000 | +99.5% | 36,109 | +10.5% | 0.00% | +50.0% |
| Q2 2016 | $1,267,000 | +7.4% | 32,675 | +12.2% | 0.00% | 0.0% |
| Q1 2016 | $1,180,000 | -53.8% | 29,127 | +1.0% | 0.00% | -33.3% |
| Q4 2015 | $2,556,000 | +19.8% | 28,828 | +0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,133,000 | -9.9% | 28,816 | -1.6% | 0.00% | 0.0% |
| Q2 2015 | $2,368,000 | +9007.7% | 29,280 | +4692.1% | 0.00% | – |
| Q1 2015 | $26,000 | +188.9% | 611 | +1.7% | 0.00% | – |
| Q4 2014 | $9,000 | +12.5% | 601 | 0.0% | 0.00% | – |
| Q3 2014 | $8,000 | -11.1% | 601 | 0.0% | 0.00% | – |
| Q2 2014 | $9,000 | -91.8% | 601 | -93.0% | 0.00% | – |
| Q1 2014 | $110,000 | – | 8,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |